Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Century Therapeutics Number of Employees 2021-2024 | IPSC

Century Therapeutics number of employees from 2021 to 2024. Number of employees can be defined as a measure of financial performance calculated as operating cash flow minus capital expenditures, expressed on a per share basis
  
Century Therapeutics Annual Employee Count
2023 165
2022 184
2021 188
2020 107
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.107B $0.002B
Century Therapeutics Inc. is a cell therapy company. It involved in developing induced pluripotent stem cell -derived cell therapies in immuno-oncology. Century Therapeutics Inc. is based in PHILADELPHIA.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $79.365B 30.41
Takeda Pharmaceutical (TAK) Japan $44.705B 9.30
Merck (MKKGY) Germany $21.616B 23.59
Astellas Pharma (ALPMY) Japan $21.191B 19.52
Sandoz Group AG (SDZNY) Switzerland $20.132B 0.00
United Therapeutics (UTHR) United States $16.822B 16.55
Summit Therapeutics (SMMT) United States $14.719B 0.00
Shionogi (SGIOY) Japan $12.704B 12.17
Neurocrine Biosciences (NBIX) United States $12.203B 32.31
Catalent (CTLT) United States $10.653B 0.00
Madrigal Pharmaceuticals (MDGL) United States $7.226B 0.00
Orion OYJ (ORINY) Finland $6.848B 19.25
Jazz Pharmaceuticals (JAZZ) Ireland $6.756B 7.16
Ionis Pharmaceuticals (IONS) United States $5.620B 0.00
Corcept Therapeutics (CORT) United States $5.245B 39.73
Crinetics Pharmaceuticals (CRNX) United States $4.548B 0.00
PTC Therapeutics (PTCT) United States $3.107B 0.00
Dyne Therapeutics (DYN) United States $2.890B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $2.603B 15.02
Catalyst Pharmaceuticals (CPRX) United States $2.581B 20.52
Arrowhead Pharmaceuticals (ARWR) United States $2.494B 0.00
Soleno Therapeutics (SLNO) United States $2.182B 0.00
Recursion Pharmaceuticals (RXRX) United States $1.867B 0.00
Centessa Pharmaceuticals (CNTA) United Kingdom $1.801B 0.00
Harrow (HROW) United States $1.626B 0.00
NewAmsterdam Pharma (NAMS) Netherlands $1.623B 0.00
Ocular Therapeutix (OCUL) United States $1.601B 0.00
Evotec AG (EVO) Germany $1.559B 0.00
BioCryst Pharmaceuticals (BCRX) United States $1.521B 0.00
Xencor (XNCR) United States $1.505B 0.00
ARS Pharmaceuticals (SPRY) United States $1.474B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $1.431B 0.00
Ardelyx (ARDX) United States $1.395B 0.00
Enliven Therapeutics (ELVN) United States $1.306B 0.00
Indivior (INDV) United States $1.266B 5.16
Cassava Sciences (SAVA) United States $1.240B 0.00
Guardian Pharmacy Services (GRDN) United States $1.157B 0.00
Bioventus (BVS) United States $1.110B 36.08
Collegium Pharmaceutical (COLL) United States $1.054B 6.05
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.031B 0.00
Cronos Group (CRON) Canada $0.841B 0.00
Relay Therapeutics (RLAY) United States $0.783B 0.00
USANA Health Sciences (USNA) United States $0.722B 13.40
Tourmaline Bio (TRML) United States $0.690B 0.00
Ironwood Pharmaceuticals (IRWD) United States $0.669B 41.90
Savara (SVRA) United States $0.609B 0.00
Exscientia (EXAI) United Kingdom $0.606B 0.00
Korro Bio (KRRO) United States $0.559B 0.00
Elite Pharmaceuticals (ELTP) United States $0.545B 51.01
Silence Therapeutics (SLN) United Kingdom $0.534B 0.00
Verve Therapeutics (VERV) United States $0.512B 0.00
OmniAb (OABI) United States $0.512B 0.00
KalVista Pharmaceuticals (KALV) United States $0.503B 0.00
Siga Technologies (SIGA) United States $0.500B 5.98
Larimar Therapeutics (LRMR) United States $0.483B 0.00
Altimmune (ALT) United States $0.483B 0.00
Xeris Biopharma Holdings (XERS) United States $0.480B 0.00
Aquestive Therapeutics (AQST) United States $0.469B 0.00
ProKidney (PROK) United States $0.452B 0.00
Zevra Therapeutics (ZVRA) United States $0.450B 0.00
4D Molecular Therapeutics (FDMT) United States $0.425B 0.00
Theravance Biopharma (TBPH) Cayman Islands $0.402B 0.00
Organogenesis (ORGO) United States $0.396B 0.00
Esperion Therapeutics (ESPR) United States $0.392B 0.00
Akebia Therapeutics (AKBA) United States $0.389B 0.00
Amylyx Pharmaceuticals (AMLX) United States $0.388B 0.00
Sage Therapeutics (SAGE) United States $0.355B 0.00
Lyell Immunopharma (LYEL) United States $0.325B 0.00
Aldeyra Therapeutics (ALDX) United States $0.308B 0.00
Avita Medical (RCEL) United States $0.290B 0.00
Lexeo Therapeutics (LXEO) United States $0.272B 0.00
Heron Therapeutics (HRTX) United States $0.270B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.248B 0.00
Nektar Therapeutics (NKTR) United States $0.245B 0.00
Acrivon Therapeutics (ACRV) United States $0.243B 0.00
Nature's Sunshine Products (NATR) United States $0.240B 16.44
Enanta Pharmaceuticals (ENTA) United States $0.235B 0.00
Pyxis Oncology (PYXS) United States $0.226B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.221B 0.00
Profound Medical (PROF) Canada $0.202B 0.00
Nanobiotix S.A (NBTX) France $0.198B 0.00
MediWound (MDWD) Israel $0.198B 0.00
Innate Pharma SA (IPHYF) France $0.180B 0.00
Context Therapeutics (CNTX) United States $0.167B 0.00
Incannex Healthcare (IXHL) Australia $0.164B 0.00
Achieve Life Sciences (ACHV) Canada $0.163B 0.00
Galectin Therapeutics (GALT) United States $0.157B 0.00
Aclaris Therapeutics (ACRS) United States $0.155B 0.00
Cardiol Therapeutics (CRDL) Canada $0.152B 0.00
CytoDyn (CYDY) United States $0.150B 0.00
VAXART, INC (VXRT) United States $0.129B 0.00
Telomir Pharmaceuticals (TELO) United States $0.126B 0.00
Fractyl Health (GUTS) United States $0.123B 0.00
Karyopharm Therapeutics (KPTI) United States $0.116B 0.00
Journey Medical (DERM) United States $0.110B 0.00
Relmada Therapeutics (RLMD) United States $0.103B 0.00
AlloVir (ALVR) United States $0.102B 0.00
Assertio Holdings (ASRT) United States $0.101B 17.67
OptiNose (OPTN) United States $0.101B 0.00
Regulus Therapeutics (RGLS) United States $0.098B 0.00
CASI Pharmaceuticals (CASI) China $0.095B 0.00
Arch Biopartners (ACHFF) Canada $0.094B 0.00
PMV Pharmaceuticals (PMVP) United States $0.084B 0.00
ElectroCore (ECOR) United States $0.079B 0.00
Metagenomi (MGX) United States $0.079B 0.00
Swiftmerge Acquisition (IVCP) United States $0.076B 368.67
ESSA Pharma (EPIX) Canada $0.072B 0.00
Vivani Medical (VANI) United States $0.070B 0.00
Prelude Therapeutics (PRLD) United States $0.066B 0.00
Nutriband (NTRB) United States $0.065B 0.00
Citius Pharmaceuticals (CTXR) United States $0.063B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.061B 0.00
Mural Oncology (MURA) Ireland $0.058B 0.00
Champions Oncology (CSBR) United States $0.058B 0.00
Protara Therapeutics (TARA) United States $0.053B 0.00
Gain Therapeutics (GANX) United States $0.053B 0.00
SCYNEXIS (SCYX) United States $0.050B 0.00
Inotiv (NOTV) United States $0.046B 0.00
Unicycive Therapeutics (UNCY) United States $0.045B 0.00
Rafael Holdings (RFL) United States $0.045B 0.00
VYNE Therapeutics (VYNE) United States $0.044B 0.00
Carisma Therapeutics (CARM) United States $0.044B 0.00
DURECT (DRRX) United States $0.042B 0.00
ProPhase Labs (PRPH) United States $0.042B 0.00
Surrozen (SRZN) United States $0.038B 0.00
BioLineRx (BLRX) Israel $0.034B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.033B 0.00
FibroGen (FGEN) United States $0.033B 0.00
Lipocine (LPCN) United States $0.033B 0.00
Oruka Therapeutics (ORKA) United States $0.033B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.031B 0.00
Iterum Therapeutics (ITRM) Ireland $0.030B 0.00
Natural Alternatives (NAII) United States $0.028B 0.00
Enlivex Therapeutics (ENLV) Israel $0.028B 0.00
GlycoMimetics (GLYC) United States $0.026B 0.00
Tempest Therapeutics (TPST) United States $0.024B 0.00
BioVie (BIVI) United States $0.023B 0.00
MEI Pharma (MEIP) United States $0.020B 0.71
Inhibikase Therapeutics (IKT) United States $0.019B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.019B 0.00
Marinus Pharmaceuticals (MRNS) United States $0.018B 0.00
TherapeuticsMD (TXMD) United States $0.018B 0.00
Lyra Therapeutics (LYRA) United States $0.017B 0.00
NLS Pharmaceutics (NLSP) Switzerland $0.017B 0.00
Cosmos Health (COSM) United States $0.016B 0.00
Minerva Neurosciences (NERV) United States $0.016B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.016B 0.00
PolyPid (PYPD) Israel $0.016B 0.00
Mannatech (MTEX) United States $0.015B 0.00
Talphera (TLPH) United States $0.015B 0.00
Scienture Holdings (SCNX) United States $0.014B 0.00
NRx Pharmaceuticals (NRXP) United States $0.014B 0.00
Avalo Therapeutics (AVTX) United States $0.014B 0.00
Nuvilex (PMCB) United States $0.013B 0.00
Vivos Therapeutics (VVOS) United States $0.013B 0.00
Indaptus Therapeutics (INDP) United States $0.012B 0.00
Addex Therapeutics (ADXN) Switzerland $0.012B 0.00
CERo Therapeutics Holdings (CERO) United States $0.011B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.011B 0.00
Dominari Holdings (DOMH) United States $0.011B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.010B 0.00
Redhill Biopharma (RDHL) Israel $0.010B 0.00
Jaguar Animal Health (JAGX) United States $0.010B 0.00
Conduit Pharmaceuticals (CDT) United States $0.009B 0.00
Traws Pharma (TRAW) United States $0.009B 0.00
TransCode Therapeutics (RNAZ) United States $0.009B 0.00
Plus Therapeutics (PSTV) United States $0.008B 0.00
Viracta Therapeutics (VIRX) United States $0.008B 0.00
Aptorum Group (APM) United Kingdom $0.007B 0.00
Klotho Neurosciences (KLTO) United States $0.007B 0.00
Biomerica (BMRA) United States $0.006B 0.00
Xenetic Biosciences (XBIO) United States $0.006B 0.00
Mangoceuticals (MGRX) United States $0.005B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.005B 0.00
SHINECO (SISI) China $0.004B 0.00
Oncternal Therapeutics (ONCT) United States $0.004B 0.00
Heatwurx (PCSA) United States $0.004B 0.00
TNF Pharmaceuticals (TNFA) United States $0.004B 0.00
Ainos (AIMD) United States $0.004B 0.00
Petros Pharmaceuticals (PTPI) United States $0.003B 0.00
InMed Pharmaceuticals (INM) Canada $0.003B 0.00
Alaunos Therapeutics (TCRT) United States $0.003B 0.00
Avenue Therapeutics (ATXI) United States $0.003B 0.09
Molecular Templates (MTEM) United States $0.003B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.003B 0.00
Phio Pharmaceuticals (PHIO) United States $0.003B 0.00
XORTX Therapeutics (XRTX) Canada $0.003B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.003B 0.00
Bio-Path Holdings (BPTH) United States $0.002B 0.00
Clearmind Medicine (CMND) Canada $0.002B 0.00
SciSparc (SPRC) Israel $0.002B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.002B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.002B 0.00
Aditxt (ADTX) United States $0.002B 0.00
China SXT Pharmaceuticals (SXTC) China $0.002B 0.00
Altamira Therapeutics (CYTO) Bermuda $0.002B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.002B 0.00
Qualigen Therapeutics (QLGN) United States $0.001B 0.00
Universe Pharmaceuticals INC (UPC) China $0.001B 0.00
PainReform (PRFX) Israel $0.000B 0.00
Qilian Holding Group (BGM) China $0.000B 0.00
Grifols, S.A (GRFS) Spain $0.000B 0.00
4D Pharma (LBPS) United Kingdom $0.000B 0.00
Procaps Group, S.A (PROC) Luxembourg $0.000B 3.42
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00
Stevanato Group S.p.A (STVN) Italy $0.000B 35.89